Dicerna
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
87 Cambridgepark Dr Fl 2, Cambridge, Mas...Phone Number
(617) 621-8097Website
www.dicerna.comRevenue
$192.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Dicerna
Founded in 2006, Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference to selectively silence genes that cause or contribute to disease. Dicerna is located in Massachusetts.Explore more
Dicerna Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dicerna your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Dicerna is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dicerna
Check if Dicerna has recently received funding, and reach out quickly before it becomes old news!
Click to see if Dicerna had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Dicerna launches new products
Dicerna, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dicerna recently announced quarterly report
Funding: Get notified immidiatlly once Dicerna has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Dicerna
Compare insights from companies similar to Dicerna, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Dicerna is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dicerna is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dicerna.
Dicerna financials insights
Gather financial insights about Dicerna, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$13M
2010
Corporate Investment
$124M
Series B
$29M
2013
Series C
$60M
2014
Stock Offering
$92.9M
2017
Share Placement
$70M
2018
Corporate Investment
$100M
Dicerna Tech Stack
A closer look at the technologies used by Dicerna
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
Dicerna is currently seeking a Director, Toxicology. (Boulder, CO)
Open Position
Dicerna News & Media
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire DicernaRNA-Based Biopharmaceuticals Market May See Big Move : Dicerna, Gradalis, Quark, Abbott Laboratories
Edison, NJ -- (SBWIRE) -- 12/22/2021 -- The Latest research study released by HTF MI "Global RNA-based Biopharmaceuticals Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major CompaniesSHAREHOLDER ALERT: WeissLaw LLP Reminds DRNA, IHC, NE, and ABTX Shareholders About Its Ongoing Investigations
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 305 Broadway, 7th Floor New...SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dicerna Pharmaceuticals, Inc. - DRNA
NEW YORK, Nov. 22, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Dicerna
Sign Up For FreeTo access detailed company insights
Founded in 2006, Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference to selectively silence genes that cause or contribute to disease. Dicerna is located in Massachusetts.... Read More
